Treatment modalities in superficial bladder cancer.
Irwin
R
R
Veterans Administration Hospital, East Orange, NJ 07018.
Zincke
H
H
Droller
M J
MJ
Prout
G R
GR
Soloway
M S
MS
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D010212:Papilloma / Q000628:therapy*; D013852:Thiotepa / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D008937:Mitomycins; D016685:Mitomycin; D004317:Doxorubicin; D013852:Thiotepa